Clinical Testing Immunogenicity Roadmap: What We’ve Learned from Case Studies
Authored by: Susan Richards, Ph.D., Group Vice President, Clinical Laboratory Science, Biologics R&D, Genzyme Corp.
* - required fields
View All Sponsors
View Media Partners
View 2013 Attendee List
Reducing and Monitoring Bioassay Variability
2013 Speaker: Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefenseDivision, Emergent BioSolutions